EN
HI
Astrazeneca Pharma India Chart
Astrazeneca Pharma India Share Key Metrics
Volume
3299.00
Market Cap
20802.50 CR
LTQ@LTP
1@8321.00
ATP
8361.11
Var Margin
16.09 %
Circuit Range
6696.5-10044.5
Delivery %
55.46 %
Value
2.76 CR
ASM/GSM
No
Market Lot
1
Summary
At 20 Mar, 2026 | 15:31, Astrazeneca Pharma India share price stands at ₹8321, showing a 49.50% -0.59 for the day. The stock’s intraday movement has stayed between ₹8301.00 and ₹8462.50, while on a 52-week basis it has fluctuated from ₹7201.15 to ₹10691.00.
In terms of trading activity, Astrazeneca Pharma India has recorded a volume of 3299 shares, with a market capitalisation of ₹25000000. The stock’s Average Traded Price (ATP) stands at ₹836111, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1,832100. The stock operates within a circuit range of ₹6696.5-10044.5, with a Value of ₹2.76 CR. The Delivery Percentage for the day is 55.46%. Additionally, Astrazeneca Pharma India currently falls under the No framework, and trades with a market lot size of 1.
Astrazeneca Pharma India Fundamentals
View MoreP/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
59.61
Sector P/B
2.6
Sec. Div. Yield
0.59
Astrazeneca Pharma India Resistance and Support
Pivot 8421.83
Resistance
First Resistance
8493.16
Second Resistance
8615.83
Third Resistance
8687.16
Support
First Support
8299.16
Second Support
8227.83
Third Support
8105.16
Astrazeneca Pharma India Corporate Actions
| Date | Agenda |
|---|---|
| 2026-02-11 | Quarterly Results |
| 2025-11-07 | Quarterly Results |
| 2025-08-14 | Quarterly Results |
| 2025-05-30 | Audited Results & Dividend |
| 2025-02-11 | Quarterly Results |
Astrazeneca Pharma India News
AstraZeneca Pharma India Ltd - 506820 - Announcement under Regulation 30 (LODR)-Resignation of Director
AstraZeneca Pharma announced the resignation of Mr. Jesús Diaz-Ropero Esteso as Non-Executive Director, effective March 19, 2026. This change is due to a transition from his current responsibilities, also impacting his roles on Board Committees.
Mar 20 2026 12:03:00
AstraZeneca Pharma India Limited
AstraZeneca Pharma India receives permission from CDSCO to import and market Durvalumab (Imfinzi). This drug is approved for an additional indication: unresectable hepatocellular carcinoma, expanding treatment options in India.
Mar 17 2026 15:03:00
Read More
About Astrazeneca Pharma India
NSE : 5610
BSE : 506820
ISIN : INE203A01020
Astrazeneca Pharma India Management
| Name | Position |
|---|---|
| Ms. Shilpa Divekar Nirula | Chairperson & Independent Director |
| Mr. Praveen Rao Akkinepally | Managing Director |
Astrazeneca Pharma India Similar Stocks
Dr. Lal Pathlabs Ltd.
1308.20
-17.20 (1.30%)
Pfizer Ltd.
4773.50
49.00 (1.04%)
Sai Life Sciences Ltd.
1000.05
-8.75 (0.87%)
Wockhardt Ltd.
1176.20
-11.10 (0.93%)
Piramal Pharma Ltd.
138.35
2.63 (1.94%)
Acutaas Chemicals Ltd.
2399.80
158.50 (7.07%)
Eris Lifesciences Ltd.
1300.10
13.90 (1.08%)
Natco Pharma Ltd.
959.20
21.15 (2.25%)
Onesource Specialty Pharma Ltd.
1456.40
-9.10 (0.62%)
Neuland Laboratories Ltd.
11995.00
-106.00 (0.88%)
Astrazeneca Pharma India FAQs
The Buying Price of Astrazeneca Pharma India share is 8321 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Astrazeneca Pharma India stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Astrazeneca Pharma India, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Astrazeneca Pharma India shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Astrazeneca Pharma India shares is 0. Useful to assess the stock's value relative to its book value.
To assess Astrazeneca Pharma India’s valuation compare Sector P/E, P/B which are 59.61 & 2.6 with sector averages, along with growth rates and financial metrics.
The Market Cap of Astrazeneca Pharma India is 20802.50 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Astrazeneca Pharma India share price is 10691.00 & 7201.15. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Astrazeneca Pharma India belongs to the Healthcare sector.
